NOVARTIS AG DRN revenue breakdown overview

NOVARTIS AG DRN revenue for the last year amounted to 311.95 B BRL, the most of which — 88.61 B BRL — came from its highest performing source at the moment, Oncology, the year earlier bringing 70.52 B BRL. The greatest contribution to the revenue figure was made by United States — last year it brought NOVARTIS AG DRN 127.12 B BRL, and the year before that — 93.19 B BRL.